INNATE PHARMA

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07K PEPTIDES 30106
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 24231
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 9197
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 6161
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 693
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 466
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 3135
 
  
 
C07D HETEROCYCLIC COMPOUNDS 3159
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0071,402 ENZYMATIC CONJUGATION OF POLYPEPTIDESJul 19, 17Mar 15, 18[C12P, C07F, C12N, C07D, C07C, G01N, C07K]
2018/0030,144 CD73 BLOCKADEFeb 19, 16Feb 01, 18[C07K]
2017/0369,573 MONOMERIC FC DOMAINSJan 04, 16Dec 28, 17[G06T, C07K, G06K]
2017/0313,773 TREATMENT OF CANCERS USING ANTI-NKG2A AGENTSOct 23, 15Nov 02, 17[A61K, C07K]
2017/0306,014 CROSS REACTIVE SIGLEC ANTIBODIESSep 09, 15Oct 26, 17[A61K, C07K]
2017/0298,131 TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIESSep 15, 15Oct 19, 17[A61K, C07K]
2017/0291,947 NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTESSep 15, 15Oct 12, 17[C07K]
2017/0267,764 ANTI-MICA ANTIBODIESMar 14, 17Sep 21, 17[C12Q, G01N, C07K]
2016/0347,853 TLR3 BINDING AGENTSJul 07, 16Dec 01, 16[A61K, C07K]
2016/0022,833 SOLID PHASE TGASE-MEDIATED CONJUGATION OF ANTIBODIESMar 14, 14Jan 28, 16[A61K, C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9828427 Anti-KIR3D antibodiesOct 28, 15Nov 28, 17[A61K, C07K]
9789182 Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancerOct 23, 13Oct 17, 17[A61K, C07K]
9764038 Enzymatic conjugation of antibodiesDec 21, 12Sep 19, 17[A61K, C07F, C12P, C07D, C12N, C07C, G01N, C07K]
9717803 Enzymatic conjugation of polypeptidesDec 21, 12Aug 01, 17[A61K, C07F, C12P, C07D, C12N, C07C, G01N, C07K]
9708403 KIR-binding agents and methods of use thereofMar 23, 15Jul 18, 17[C07H, C12P, C12N, C07K]
9427478 Enzymatic conjugation of polypeptidesDec 23, 14Aug 30, 16[A61K, C07K]
9388246 TLR3 binding agentsMay 05, 11Jul 12, 16[A61K, C12N, A61P, C07K]
9181341 Anti-KIR3D antibodiesJan 15, 10Nov 10, 15[A61K, C12P, G01N, C07K]
8735624 Polymorphic form of CHDMAPP, method of preparation thereof, and pharmaceutical composition comprising sameSep 08, 09May 27, 14[C07F]
8715667 Methods of treating patients having TLR3-positive cancerAug 15, 12May 06, 14[A61K, G01N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0136,272 METHODS FOR RESTORING CORTICOSTEROID SENSITIVITYAbandonedMay 13, 14May 19, 16[A61K, C07K]
2016/0002,345 A COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMENT OF PERIPHERAL T CELL LYMPHOMAAbandonedFeb 20, 14Jan 07, 16[G01N, C07K]
2014/0234,323 COMPOSITIONS AND METHODS FOR DETECTING TLR3AbandonedMay 02, 14Aug 21, 14[G01N, C07K]
2014/0234,342 NKP46-MEDIATED NK CELL TUNINGAbandonedJun 21, 12Aug 21, 14[C07K]
2014/0065,154 TLR3 BINDING AGENTSAbandonedJan 10, 12Mar 06, 14[A61K, C07K]
2010/0291,118 Class of Gamma Delta T Cells Activators and Use ThereofAbandonedJul 28, 10Nov 18, 10[A61K, C07H, C07F, C12N, A61P, C07K, C11C]
2008/0300,222 Phosphoantigen Salts Of Organic Bases And Methods For Their CrystallizationAbandonedOct 05, 06Dec 04, 08[A61K, C07F, A61P]
2005/0196,385 Methods for producing gamma delta t cellsAbandonedAug 19, 04Sep 08, 05[A61K, C12N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.